|Page (1) of 1 - 09/07/13||email article||print page|
This morning, Trovagene (TROV) announced it has entered into a clinical collaboration agreement with the University of Southern California study the effectiveness of the company's cell-free DNA assay. The goal is to show that Trovagene's technology is able to identify the cancer's genomic changes following treatment and to track the progression of the disease.
|Cancer Monitoring Technology In The Future?|
Source:GrabNetworks (c). All Rights Reserved